A new European Citizens’ Initiative called PsychedeliCare is pushing for the legal framework for psychedelic-assisted therapies in the E.U., citing their potential for treating mental health disorders. The initiative highlights the significant economic burden of mental health issues and the lack of new psychiatric treatments in the region, emphasizing the need for innovative approaches. With growing global support for psychedelic research and therapy, PsychedeliCare aims to position Europe as a leader in this field.